Nov. 25 at 9:15 AM
$CDIO Cardio Diagnostics expands into 15 new medical practices across the U.S., boosting demand for its AI-powered Epi+Gen CHD and PrecisionCHD tests. With heart disease still the No. 1 killer, CDIO’s precision cardiovascular platform positions the company for explosive growth in 2025 and beyond. https://biotechhealthx.com/biotech-news/cardio-diagnostics-cdio-surges-as-15-new-provider-partnerships-accelerate-national-adoption/